{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T03:33:00Z","timestamp":1776828780330,"version":"3.51.2"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T00:00:00Z","timestamp":1562976000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T00:00:00Z","timestamp":1562976000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s10147-019-01507-w","type":"journal-article","created":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T06:02:46Z","timestamp":1562997766000},"page":"1429-1439","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Forkhead box protein O1 (FOXO1) and paired box gene 3 (PAX3) overexpression is associated with poor prognosis in patients with cervical cancer"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0648-4021","authenticated-orcid":false,"given":"Doo Byung","family":"Chay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5263-4855","authenticated-orcid":false,"given":"Gwan Hee","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanghee","family":"Nam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6177-1648","authenticated-orcid":false,"given":"Hanbyoul","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon-Yong","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen M.","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,13]]},"reference":[{"key":"1507_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL et al (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87\u2013108","journal-title":"CA Cancer J Clin"},{"key":"1507_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/GCO.0000000000000234","volume":"28","author":"A Duenas-Gonzalez","year":"2016","unstructured":"Duenas-Gonzalez A, Campbell S (2016) Global strategies for the treatment of early-stage and advanced cervical cancer. Curr Opin Obstet Gynecol 28:11\u201317","journal-title":"Curr Opin Obstet Gynecol"},{"key":"1507_CR3","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1002\/cncr.30667","volume":"123","author":"W Small Jr","year":"2017","unstructured":"Small W Jr, Bacon MA, Bajaj A et al (2017) Cervical cancer: a global health crisis. Cancer 123:2404\u20132412","journal-title":"Cancer"},{"key":"1507_CR4","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ogc.2012.02.008","volume":"39","author":"JS Lea","year":"2012","unstructured":"Lea JS, Lin KY (2012) Cervical cancer. Obstet Gynecol Clin N Am 39:233\u2013253","journal-title":"Obstet Gynecol Clin N Am"},{"key":"1507_CR5","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.lfs.2017.11.030","volume":"193","author":"YQ Xing","year":"2018","unstructured":"Xing YQ, Li A, Yang Y et al (2018) The regulation of FOXO1 and its role in disease progression. Life Sci 193:124\u2013131","journal-title":"Life Sci"},{"key":"1507_CR6","first-page":"925350","volume":"2014","author":"Y Wang","year":"2014","unstructured":"Wang Y, Zhou Y, Graves DT (2014) FOXO transcription factors: their clinical significance and regulation. Biomed Res Int 2014:925350","journal-title":"Biomed Res Int"},{"key":"1507_CR7","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.2174\/138945011796150280","volume":"12","author":"H Lu","year":"2011","unstructured":"Lu H, Huang H (2011) FOXO1: a potential target for human diseases. Curr Drug Targets 12:1235\u20131244","journal-title":"Curr Drug Targets"},{"key":"1507_CR8","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1038\/onc.2008.24","volume":"27","author":"Z Fu","year":"2008","unstructured":"Fu Z, Tindall DJ (2008) FOXOs, cancer and regulation of apoptosis. Oncogene 27:2312\u20132319","journal-title":"Oncogene"},{"key":"1507_CR9","doi-asserted-by":"publisher","first-page":"6605","DOI":"10.4238\/2015.June.18.3","volume":"14","author":"B Zhang","year":"2015","unstructured":"Zhang B, Gui LS, Zhao XL et al (2015) FOXO1 is a tumor suppressor in cervical cancer. Genet Mol Res 14:6605\u20136616","journal-title":"Genet Mol Res"},{"key":"1507_CR10","first-page":"1297","volume":"9","author":"L Huang","year":"2017","unstructured":"Huang L, Huang Z, Fan Y et al (2017) FOXC1 promotes proliferation and epithelial-mesenchymal transition in cervical carcinoma through the PI3K-AKT signal pathway. Am J Transl Res 9:1297\u20131306","journal-title":"Am J Transl Res"},{"key":"1507_CR11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.gene.2018.04.087","volume":"666","author":"S Boudjadi","year":"2018","unstructured":"Boudjadi S, Chatterjee B, Sun W et al (2018) The expression and function of PAX3 in development and disease. Gene 666:145\u2013157","journal-title":"Gene"},{"key":"1507_CR12","doi-asserted-by":"publisher","first-page":"e29379","DOI":"10.1371\/journal.pone.0029379","volume":"6","author":"XD Wang","year":"2011","unstructured":"Wang XD, Morgan SC, Loeken MR (2011) Pax3 stimulates p53 ubiquitination and degradation independent of transcription. PLoS ONE 6:e29379","journal-title":"PLoS ONE"},{"key":"1507_CR13","doi-asserted-by":"crossref","first-page":"54744","DOI":"10.18632\/oncotarget.10753","volume":"7","author":"W Liu","year":"2016","unstructured":"Liu W, Sui F, Liu J et al (2016) PAX3 is a novel tumor suppressor by regulating the activities of major signaling pathways and transcription factor FOXO3a in thyroid cancer. Oncotarget 7:54744\u201354757","journal-title":"Oncotarget"},{"key":"1507_CR14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228\u2013247","journal-title":"Eur J Cancer"},{"key":"1507_CR15","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method. Methods 25:402\u2013408","journal-title":"Methods"},{"key":"1507_CR16","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.humpath.2007.02.016","volume":"38","author":"R Li","year":"2007","unstructured":"Li R, Erdamar S, Dai H et al (2007) Forkhead protein FKHR and its phosphorylated form p-FKHR in human prostate cancer. Hum Pathol 38:1501\u20131507","journal-title":"Hum Pathol"},{"key":"1507_CR17","doi-asserted-by":"crossref","first-page":"96313","DOI":"10.18632\/oncotarget.22029","volume":"8","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Jia L, Zhang Y et al (2017) Higher expression of FOXOs correlates to better prognosis of bladder cancer. Oncotarget 8:96313\u201396322","journal-title":"Oncotarget"},{"key":"1507_CR18","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00018-015-2112-y","volume":"73","author":"A Coomans de Brachene","year":"2016","unstructured":"Coomans de Brachene A, Demoulin JB (2016) FOXO transcription factors in cancer development and therapy. Cell Mol Life Sci 73:1159\u20131172","journal-title":"Cell Mol Life Sci"},{"key":"1507_CR19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.4161\/cbt.12.4.15954","volume":"12","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Gan B, Liu D et al (2011) FoxO family members in cancer. Cancer Biol Ther 12:253\u2013259","journal-title":"Cancer Biol Ther"},{"key":"1507_CR20","doi-asserted-by":"publisher","first-page":"655","DOI":"10.7150\/jca.6554","volume":"5","author":"SB Prasad","year":"2014","unstructured":"Prasad SB, Yadav SS, Das M et al (2014) Down regulation of FOXO1 promotes cell proliferation in cervical cancer. J Cancer 5:655\u2013662","journal-title":"J Cancer"},{"key":"1507_CR21","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","volume":"382","author":"EJ Crosbie","year":"2013","unstructured":"Crosbie EJ, Einstein MH, Franceschi S et al (2013) Human papillomavirus and cervical cancer. Lancet 382:889\u2013899","journal-title":"Lancet"},{"key":"1507_CR22","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.immuni.2014.10.013","volume":"41","author":"MM Staron","year":"2014","unstructured":"Staron MM, Gray SM, Marshall HD et al (2014) The transcription factor FoxO1 sustains expression of the inhibitory receptor PD-1 and survival of antiviral CD8(+) T cells during chronic infection. Immunity 41:802\u2013814","journal-title":"Immunity"},{"key":"1507_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s12031-011-9677-1","volume":"47","author":"J Chen","year":"2012","unstructured":"Chen J, Xia L, Wu X et al (2012) Clinical significance and prognostic value of PAX3 expression in human glioma. J Mol Neurosci 47:52\u201358","journal-title":"J Mol Neurosci"},{"key":"1507_CR24","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/carcin\/bgv009","volume":"36","author":"L Zhang","year":"2015","unstructured":"Zhang L, Xia L, Zhao L et al (2015) Activation of PAX3-MET pathways due to miR-206 loss promotes gastric cancer metastasis. Carcinogenesis 36:390\u2013399","journal-title":"Carcinogenesis"},{"key":"1507_CR25","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/his.12347","volume":"64","author":"Y Xu","year":"2014","unstructured":"Xu Y, Shao QS, Yao HB et al (2014) Overexpression of FOXC1 correlates with poor prognosis in gastric cancer patients. Histopathology 64:963\u2013970","journal-title":"Histopathology"},{"key":"1507_CR26","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s13277-012-0629-3","volume":"34","author":"LX Wei","year":"2013","unstructured":"Wei LX, Zhou RS, Xu HF et al (2013) High expression of FOXC1 is associated with poor clinical outcome in non-small cell lung cancer patients. Tumour Biol 34:941\u2013946","journal-title":"Tumour Biol"},{"key":"1507_CR27","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.cell.2007.01.003","volume":"128","author":"Z Tothova","year":"2007","unstructured":"Tothova Z, Kollipara R, Huntly BJ et al (2007) FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128:325\u2013339","journal-title":"Cell"},{"key":"1507_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cca.2015.03.005","volume":"445","author":"S Dasari","year":"2015","unstructured":"Dasari S, Wudayagiri R, Valluru L (2015) Cervical cancer: biomarkers for diagnosis and treatment. Clin Chim Acta 445:7\u201311","journal-title":"Clin Chim Acta"},{"key":"1507_CR29","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10120-013-0314-2","volume":"17","author":"J Park","year":"2014","unstructured":"Park J, Ko YS, Yoon J et al (2014) The forkhead transcription factor FOXO1 mediates cisplatin resistance in gastric cancer cells by activating phosphoinositide 3-kinase\/Akt pathway. Gastric Cancer 17:423\u2013430","journal-title":"Gastric Cancer"},{"key":"1507_CR30","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1093\/carcin\/bgn092","volume":"29","author":"CY Han","year":"2008","unstructured":"Han CY, Cho KB, Choi HS et al (2008) Role of FoxO1 activation in MDR1 expression in adriamycin-resistant breast cancer cells. Carcinogenesis 29:1837\u20131844","journal-title":"Carcinogenesis"},{"key":"1507_CR31","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/sj.bjc.6604279","volume":"98","author":"T Goto","year":"2008","unstructured":"Goto T, Takano M, Hirata J et al (2008) The involvement of FOXO1 in cytotoxic stress and drug-resistance induced by paclitaxel in ovarian cancers. Br J Cancer 98:1068\u20131075","journal-title":"Br J Cancer"},{"key":"1507_CR32","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/978-1-61779-024-9_8","volume":"717","author":"M Grunkin","year":"2011","unstructured":"Grunkin M, Raundahl J, Foged NT (2011) Practical considerations of image analysis and quantification of signal transduction IHC staining. Methods Mol Biol 717:143\u2013154","journal-title":"Methods Mol Biol"},{"key":"1507_CR33","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1365-2559.2005.02322.x","volume":"48","author":"OW Tawfik","year":"2006","unstructured":"Tawfik OW, Kimler BF, Davis M et al (2006) Comparison of immunohistochemistry by automated cellular imaging system (ACIS) versus fluorescence in-situ hybridization in the evaluation of HER-2\/neu expression in primary breast carcinoma. Histopathology 48:258\u2013267","journal-title":"Histopathology"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-019-01507-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-019-01507-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-019-01507-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,11]],"date-time":"2020-07-11T23:24:05Z","timestamp":1594509845000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-019-01507-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,13]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["1507"],"URL":"https:\/\/doi.org\/10.1007\/s10147-019-01507-w","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,13]]},"assertion":[{"value":"15 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}